Company: SINT
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010496
Chunk: 15

Company: Sintx Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 8
Chunk 15
---
2024, in connection with securing commercial liability insurance,
the Company entered into a Premium Finance Arrangement to extend the premium payment out for a period of 10 months. The Company paid a
total of $26,000 up front toward the insurance premium and financed approximately $117,000. The Company made 10 equal payments under the
terms of the Premium Finance Agreement. The Premium Finance Agreement bears interest at an annual percentage rate of 8.75%. The loan was
paid in full during the first quarter of 2025 and there was no outstanding balance as of March 31, 2025.

In March 2025, in connection with securing Director
and Officer professional liability insurance, the Company entered into a Premium Finance Arrangement to extend the premium payment out
for a period of 10 months. The Company paid a total of $26,000 up front toward the insurance premium and financed approximately $145,000.
The Company will make 10 equal payments under the terms of the Premium Finance Agreement. The Premium Finance Agreement bears interest
at an annual percentage rate of 7.450%. The outstanding balance as of March 31, 2025, totaled $131,000.

8. Equity

2025 Capital Raise and registration of shares

On February 20, 2025, entered into a private placement
transaction pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited
investors for aggregate gross proceeds of $5.0 million, before deducting fees to the placement agent and other expenses payable by the
Company in connection with the Private Placement. The Company intends to use the net proceeds from the Private Placement for general corporate
purposes and working capital. H.C. Wainwright & Co. (“Wainwright”), acted as the exclusive placement agent for the Private
Placement, which closed on February 25, 2025. As part of the Private Placement, the Company issued (i) 1,171,189 shares of the Company’s
common stock, par value $0.01 per share (“Common Stock”), (ii) pre-funded warrants to purchase 278,098 shares of Common Stock
(the “Pre-Funded Warrants”) with an exercise price of $0.0001 per share, and (iii) warrants to purchase 1,449,287 shares of
Common Stock (the “Common Warrants,” together with the Pre-Funded Warrants, the “Warrants”) (the Warrants, together
with the